GG

Gaddiel Galarza-Munoz

University Of Texas System: 6 patents #431 of 6,559Top 7%
DU Duke University: 2 patents #648 of 2,315Top 30%
University of California: 2 patents #4,561 of 18,278Top 25%
📍 Galveston, TX: #41 of 342 inventorsTop 15%
🗺 Texas: #24,375 of 125,132 inventorsTop 20%
Overall (All Time): #772,163 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
12359204 Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer Mariano A. Garcia-Blanco, Shelton S. Bradrick 2025-07-15
12247206 Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer Mariano A. Garcia-Blanco, Shelton S. Bradrick 2025-03-11
12203138 Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932) Mariano A. Garcia-Blanco, Simon G. Gregory, Farren B. S. Briggs, Lisa F. Barcellos, Shelton S. Bradrick +2 more 2025-01-21
11807853 Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer Mariano A. Garcia-Blanco, Shelton S. Bradrick 2023-11-07
11118186 Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer Mariano A. Garcia-Blanco, Shelton S. Bradrick 2021-09-14
10961581 Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932) Mariano A. Garcia-Blanco, Simon G. Gregory, Farren B. S. Briggs, Lisa F. Barcellos, Shelton S. Bradrick +2 more 2021-03-30